Ethan Granger
Novo Nordisk Makes Job Cuts at Major U.S. Plant
Novo Nordisk trims its U.S. workforce amid surging demand for diabetes and obesity drugs, reflecting broader changes in pharmaceutical manufacturing.
Impact of Frozen Grants on Drug Development: A Deep Dive
Federal funding freezes under the Trump administration jeopardize university-led drug research behind lifesaving drugs like Ozempic, Keytruda, and Truvada.
Biomea’s Icovamenib Drug Shows Potential for Diabetes Patients
Biomea’s icovamenib shows lasting blood sugar reduction in type 2 diabetes, offering new hope for patients unresponsive to GLP-1 treatments.
Costco’s New Cheesy Sourdough Bread Sparks Fan Excitement
Costco revives its fan-favorite cheesy sourdough loaf—warm, gooey, and ready in minutes—perfect for cozy fall meals and family gatherings.
Dengue Outbreak in Bangladesh Escalates, Urgent Action Needed
Bangladesh reports over 50,000 dengue cases and 215 deaths, with experts warning the outbreak could worsen due to climate change…
Skye’s Obesity Drug Fails Key Mid-Stage Trial, Share Prices Plummet
Skye pivots to obesity drug nimacimab after trial setbacks, touting safety and muscle retention benefits amid investor skepticism.